Versant Venture Capital VI, L.P. is 10% Owner at Akero Therapeutics, Inc. (AKRO). They have made 9 open-market trades across 4 companies since 2019, most recently 2025-09-18.
1 open-market purchase totalling $6.4M since 2019, against 8 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 38% | 25% | 75% |
| Avg Move | +5.8% | +7.8% | -21.6% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LENZ | SELL | 2025-09-18 | 2025-09-22 | $42.00 | $8.8M | +16.4% | -21.2% | -57.5% |
| LENZ | SELL | 2025-08-15 | 2025-08-19 | $39.34 | $20.5M | +3.8% | +12.1% | -30.9% |
| GLUE | SELL | 2024-10-28 | 2024-10-30 | $9.44 | $2.8M | +8.3% | +12.1% | -37.0% |
| GLUE | SELL | 2024-09-20 | 2024-09-24 | $6.53 | $14.8M | -11.0% | -14.9% | +24.8% |
| TPST | SELL | 2024-08-08 | 2024-08-12 | $1.19 | $1.4M | +46.0% | +38.0% | +10.0% |
| OYST | SELL · 10b5-1 | 2021-10-18 | 2021-10-20 | $14.83 | $8.2M | -0.6% | -14.2% | +2.8% |
| BDTX | SELL · 10b5-1 | 2020-11-12 | 2020-11-13 | $34.15 | $533K | +0.2% | +2.8% | -16.4% |
| BDTX | SELL · 10b5-1 | 2020-10-06 | 2020-10-08 | $33.44 | $1.5M | -11.7% | -3.9% | -0.4% |
| AKRO | SELL | 2019-12-27 | 2019-12-31 | $24.20 | $18.8M | -9.9% | +11.6% | -23.0% |
| AKRO | SELL | 2019-12-20 | 2019-12-26 | $20.97 | $1.5M | -13.3% | +3.6% | -26.5% |
| AKRO | SELL | 2019-12-17 | 2019-12-19 | $19.57 | $339K | +6.2% | +21.3% | -32.3% |
| AKRO | BUY | 2019-06-24 | 2019-06-25 | $16.00 | $6.4M | -2.7% | +38.5% | +8.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.